Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized dexmedetomidine dose comparison for awake fiberoptic intubation
PACTR202602489190466Phase 1Not yet recruiting
- Sponsor
- Alaa Eldin Abdel Sami Aiad
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine (2 arms), sponsored by Alaa Eldin Abdel Sami Aiad. Primary endpoints: Mean arterial pressure at scope insertion, Heart rate at scope insertion and 2 more. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on PACTR202602489190466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202602489190466.